New gout drug HEC93077 passes early safety tests in chinese volunteers
NCT ID NCT05127772
First seen May 14, 2026 · Last updated May 22, 2026 · Updated 2 times
Summary
This early-stage trial tested a new drug called HEC93077 in 126 healthy Chinese volunteers and people with high uric acid (hyperuricemia), a condition that can lead to gout. The main goals were to check the drug's safety, how the body processes it, and whether food affects its absorption. Results will help decide if further studies are warranted for managing gout.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GOUT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peking Universicity Care of Luzhong Hospital
Zibo, Shandong, 255400, China
Conditions
Explore the condition pages connected to this study.